Woodline Partners’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.2M	Buy	306,724 +353	+0.1%	+$4.84K	0.02%	597
2025 Q1	$3.39M	Buy	306,371 +729	+0.2%	+$8.06K	0.02%	591
2024 Q4	$3.26M	Hold	305,642	–	–	0.02%	571
2024 Q3	$3.88M	Buy	305,642 +1,902	+0.6%	+$24.2K	0.03%	416
2024 Q2	$5.1M	Buy	+303,740	New	+$5.1M	0.05%	333